Mainak Sengupta

Established in 2008 by a group of visionary investors, Alteus began as a specialized player in the field of Central Nervous System (CNS) therapies. Over the past 16 years, the company has transformed into a leading mid-sized pharmaceutical unicorn, with a 220 Cr topline business and a diversified portfolio spanning multiple therapeutic areas. With a nationwide presence, Alteus operates across all geographies in India and is supported by a highly skilled workforce of over 1500 professionals, all aligned towards a shared mission of delivering quality healthcare solutions. Alteus has firmly positioned itself as one of the fastest-growing pharmaceutical companies in India and currently ranks 89th in the Rx Share category. Its remarkable growth trajectory has been recognized with prestigious industry accolades, including the Atmanirbhar Bharat-Vision of New India Award from the Indian Achievers Awards (conferred by NITI Aayog) and the Outstanding Company of the Year 2021-22 (East Zone) award by a leading media house in Bengal.